日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships.

SDHB 变异体的功能表征阐明了遗传性嗜铬细胞瘤和副神经节瘤的风险以及基因型-表型关系。

Lee Sooyeon, Needleman Leor, Park Julie, Schugar Rebecca C, Guo Qianjin, Ford James M, Annes Justin P

Evaluating a Mendelian Risk Prediction Model That Aggregates Across Genes and Cancers

评估一个跨基因和癌症聚合的孟德尔风险预测模型

Liang, Jane W; Idos, Gregory E; Hong, Christine; Shannon, Kristen M; Bear, Lauren M; Pichardo, Jennifer Morales; Guan, Zoe; McCarthy, Anne Marie; Ford, James M; Kurian, Allison W; Gruber, Stephen B; Braun, Danielle; Parmigiani, Giovanni

Author Correction: Global loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesis

作者更正:早期结直肠癌发生过程中启动子-增强子连接的整体丧失和基因表达的重新平衡

Zhu, Yizhou; Lee, Hayan; White, Shannon; Weimer, Annika K; Monte, Emma; Horning, Aaron; Nevins, Stephanie A; Esplin, Edward D; Paul, Kristina; Krieger, Gat; Shipony, Zohar; Chiu, Roxanne; Laquindanum, Rozelle; Karathanos, Thomas V; Chua, Melissa W Y; Mills, Meredith; Ladabaum, Uri; Longacre, Teri; Shen, Jeanne; Jaimovich, Ariel; Lipson, Doron; Kundaje, Anshul; Greenleaf, William J; Curtis, Christina; Ford, James M; Snyder, Michael P

A triple-punch approach: methionine restriction enhances combination inhibitors in brain metastatic triple-negative breast cancer

三重打击策略:限制蛋氨酸摄入可增强联合抑制剂治疗脑转移性三阴性乳腺癌的疗效

Suresh, Samyuktha; Ford, James M

Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing

多重基因检测后患者的乳腺癌MRI筛查

Naghi, Leah A; Culver, Julie O; Ricker, Charité; Sturgeon, Duveen; Kingham, Kerry; Hodan, Rachel; Chun, Nicolette M; Kidd, John; Bonner, Joseph; Hong, Christine; Morales-Pichardo, Jennifer; Mills, Meredith; Lindsey, Sidney; McDonnell, Kevin; Ladabaum, Uri; Ford, James M; Gruber, Stephen B; Kurian, Allison W; Idos, Gregory E

MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis

MDM2抑制与TP53改变的克隆性造血的出现有关

Khanna, Vishesh; Eslami, Gohar; Reyes, Rochelle; Diep, Robert; Fernandez-Pol, Sebastian; Stehr, Henning; Suarez, Carlos Jose; Pinto, Harlan; Ford, James M; Zhang, Tian Yi; Chen, Christopher T

A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death

一项包含20个特征的放射组学特征分析可识别三阴性乳腺癌高死亡风险患者。

Noor, Humaira; Zheng, Yuanning; Mantz, Adam B; Zhou, Ryle; Kozlov, Andrew; DeMartini, Wendy B; Chen, Shu-Tian; Okamoto, Satoko; Ikeda, Debra M; Telli, Melinda L; Kurian, Allison W; Ford, James M; Vinayak, Shaveta; Satoyoshi, Mina; Joshi, Vishal; Mattonen, Sarah A; Lee, Kevin; Gevaert, Olivier; Sledge, George W; Itakura, Haruka

PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cells

在乳腺癌细胞中,PARP抑制剂和PRMT5抑制剂的协同作用与BRCA1/2和MTAP状态无关。

Suresh, Samyuktha; McPherson, Lisa; Ford, James M

Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNA.

SMUG1小分子激活剂可增强DNA中嘧啶损伤的修复

Gao Yixuan, McPherson Lisa, Adimoolam Shanthi, Suresh Samyuktha, Wilson David L, Das Ishani, Park Elizabeth R, Ng Christine S C, Jun Yong Woong, Ford James M, Kool Eric T

An eMERGEing definition of patient engagement in genetic counseling

遗传咨询中患者参与的新兴定义

Fung, Jacqueline; Rashkin, Misha; Barton, Claire; Grajales, Lizette; Jan, Cheng-Wei; Lara-Otero, Karlena; Narain, Anjali; Rios-Ventura, Sonia; Rowe-Teeter, Courtney; Torres Zapata, Astrid; Tucker, Brianna; Ford, James M